Ryan D. Schulteis

ORCID: 0000-0002-7340-8504
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Venous Thromboembolism Diagnosis and Management
  • Immune Cell Function and Interaction
  • Acute Myocardial Infarction Research
  • Colorectal Cancer Screening and Detection
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Peripheral Artery Disease Management
  • Healthcare Technology and Patient Monitoring
  • COVID-19 and healthcare impacts
  • Atrial Fibrillation Management and Outcomes
  • T-cell and B-cell Immunology
  • Immune cells in cancer
  • Non-Invasive Vital Sign Monitoring
  • Colorectal Cancer Surgical Treatments
  • Cardiac Health and Mental Health
  • Cancer Cells and Metastasis
  • Urinary Bladder and Prostate Research
  • Emergency and Acute Care Studies
  • Vascular Procedures and Complications
  • Immunotherapy and Immune Responses
  • Cardiovascular Function and Risk Factors
  • Patient Satisfaction in Healthcare
  • Urinary Tract Infections Management
  • Coronary Interventions and Diagnostics
  • Aortic aneurysm repair treatments
  • Quality and Safety in Healthcare

Durham VA Medical Center
2014-2023

Duke University Hospital
2015-2023

Durham VA Health Care System
2020-2021

Duke University
2014-2020

Duke Medical Center
2005-2017

Duke University Health System
2015-2016

Versiti Blood Center of Wisconsin
2006-2008

BACKGROUND The long‐term safety of paclitaxel‐coated devices (PCDs; drug‐coated balloon or drug‐eluting stent) for peripheral endovascular intervention is uncertain. We used data from the Veterans Health Administration to evaluate association between PCDs, mortality, and cause death. METHODS AND RESULTS Using Corporate Data Warehouse in conjunction with International Classification Diseases, Tenth Revision ( ICD‐10 ) Procedure Coding System, Current Procedural Terminology, Healthcare Common...

10.1161/jaha.120.018149 article EN cc-by-nc-nd Journal of the American Heart Association 2021-02-08

Background Systematic surveillance for venous thromboembolism (VTE) in the United States has been recommended by several organizations. Despite adoption of electronic medical records (EMRs) most health care providers and facilities, however, systematic VTE is not available. Objectives This article develops a comprehensive, population-based strategy defined geographical region. Methods The primary combined computerized searches EMR with manual review imaging data at Duke University Health...

10.1055/s-0039-1693711 article EN Applied Clinical Informatics 2019-05-01

ABSTRACT Patient-physician communication is an integral part of high-quality patient care and expectation the Clinical Learning Environment Review program.Background This quality improvement initiative evaluated impact educational audit feedback intervention on frequency use 2 tools—business cards white boards—to improve provider identification.Objective before-after study utilized surveys to determine ability those patients name recognize their physicians. The before phase began in July...

10.4300/jgme-d-15-00067.1 article EN Journal of Graduate Medical Education 2016-03-01

Venous thromboembolism (VTE) affects approximately 1-2 individuals per 1000 annually and is associated with an increased risk for pulmonary hypertension, postthrombotic syndrome, recurrent VTE.

10.1002/rth2.12769 article EN cc-by-nc-nd Research and Practice in Thrombosis and Haemostasis 2022-07-01

An abstract is not available for this content so a preview has been provided. Please use the Get access link above information on how to content.

10.1017/ice.2020.357 article EN Infection Control and Hospital Epidemiology 2020-08-19

Background It is unclear whether diagnostic protocols based on cardiac markers to identify low‐risk chest pain patients suitable for early release from the emergency department can be applied older than 65 years or with traditional risk factors. Methods and Results In a single‐center retrospective study of 231 consecutive high‐risk factor burden in which first troponin ( cT n) level was measured second n sample drawn 4 14 hours later, we compared performance modified 2‐Hour Accelerated...

10.1161/jaha.115.002351 article EN cc-by-nc-nd Journal of the American Heart Association 2015-12-01

Introduction: The strong correlation between early termination of dual antiplatelet therapy and stent thrombosis in patients treated with drug-eluting stents (DES) warrants emphasis on appropriate selection for DES. Using a simple questionnaire administered pre-procedurally, we aimed to determine which clinical factors might predict the use DES during PCI. Hypothesis: A “yes” response any item pre-PCI (table 1) will decrease odds Methods: Durham Veterans Affairs electronic health record,...

10.1161/circ.130.suppl_2.19334 article EN Circulation 2014-11-25

10.1016/j.gie.2015.03.1407 article EN Gastrointestinal Endoscopy 2015-04-27
Coming Soon ...